| Year |
Citation |
Score |
| 2017 |
Lamberts JT, Rosenthal LD, Jutkiewicz EM, Traynor JR. Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence. Psychopharmacology. PMID 28971229 DOI: 10.1007/S00213-017-4742-2 |
0.547 |
|
| 2013 |
Lamberts JT, Smith CE, Li MH, Ingram SL, Neubig RR, Traynor JR. Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 4369-77. PMID 23467353 DOI: 10.1523/Jneurosci.5470-12.2013 |
0.59 |
|
| 2013 |
Lamberts JT, Traynor JR. Opioid receptor interacting proteins and the control of opioid signaling. Current Pharmaceutical Design. 19: 7333-47. PMID 23448476 DOI: 10.2174/138161281942140105160625 |
0.541 |
|
| 2011 |
Lamberts JT, Jutkiewicz EM, Mortensen RM, Traynor JR. μ-Opioid receptor coupling to Gα(o) plays an important role in opioid antinociception. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2041-53. PMID 21654736 DOI: 10.1038/Npp.2011.91 |
0.552 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Lamberts JT, Hildebrandt EN, Brundin P. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: a speculative synthesis. Neurobiology of Disease. 77: 276-83. PMID 25046996 DOI: 10.1016/J.Nbd.2014.07.002 |
0.274 |
|
| 2015 |
Brundin P, Atkin G, Lamberts JT. Basic science breaks through: New therapeutic advances in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1521-7. PMID 26177603 DOI: 10.1002/Mds.26332 |
0.266 |
|
| 2015 |
Reyes JF, Olsson TT, Lamberts JT, Devine MJ, Kunath T, Brundin P. A cell culture model for monitoring α-synuclein cell-to-cell transfer. Neurobiology of Disease. 77: 266-75. PMID 25046995 DOI: 10.1016/J.Nbd.2014.07.003 |
0.253 |
|
| 2020 |
Von Seggern M, Szarowicz C, Swanson M, Cavotta S, Pike ST, Lamberts JT. Purine molecules in Parkinson's disease: analytical techniques and clinical implications. Neurochemistry International. 104793. PMID 32650026 DOI: 10.1016/J.Neuint.2020.104793 |
0.249 |
|
| 2017 |
Lamberts JT, Brundin P. Axonal transport dysfunction in neurodegenerative diseases: the "holy grail" for developing disease modifying therapies? Neurobiology of Disease. 105: 271-272. PMID 28734388 DOI: 10.1016/J.Nbd.2017.06.018 |
0.222 |
|
| 2019 |
Nybo SE, Lamberts JT. Integrated use of LC/MS/MS and LC/Q-TOF/MS targeted metabolomics with automated label-free microscopy for quantification of purine metabolites in cultured mammalian cells. Purinergic Signalling. PMID 30604179 DOI: 10.1007/S11302-018-9643-2 |
0.217 |
|
| 2016 |
Zwart CR, Lamberts JT. Not all dopamine neurons are created equal: Functional heterogeneity of midbrain dopamine axons. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27643922 DOI: 10.1002/Mds.26801 |
0.207 |
|
| 2024 |
Ding Q, Lamberts J, Konieczny AM, Bringedahl TB, Torres Garcia KY. Association of Autoimmune Disorders and Disease-modifying Antirheumatic Drugs with the Risk of Alzheimer's and/or Dementia: A Population Study Using Medicare Beneficiary Data. Current Alzheimer Research. PMID 38288824 DOI: 10.2174/0115672050289966240110041616 |
0.035 |
|
| 2021 |
Kennedy DR, Clapp P, DeLuca JL, Filtz TM, Kroon L, Lamberts JT, Oliphant CM, Prescott WA, Ray SD. Enhancing Pharmacy Faculty Well-Being and Productivity while Reducing Burnout. American Journal of Pharmaceutical Education. 8764. PMID 34507961 DOI: 10.5688/ajpe8764 |
0.029 |
|
| 2021 |
Lamberts JT, Vandiver JW, Daugherty KK, DiVall MV, Lebovitz L, Roberts SC. Perceptions of programs that orient non-practice faculty to the pharmacy profession: A pilot study. Currents in Pharmacy Teaching & Learning. 13: 812-818. PMID 34074512 DOI: 10.1016/j.cptl.2021.03.004 |
0.01 |
|
| Hide low-probability matches. |